• Return to Headlines

Biomarin Pharmac: New 52-Week Low Set Today (BMRN)

By James Quinn

Shares of Biomarin Pharmac (NASDAQ:BMRN) traded today at $72.16, breaking its 52-week low. So far today approximately 93,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares.

In the past 52 weeks, Biomarin Pharmac share prices have been bracketed by a current low of $72.16 and a high of $106.74 and are now at $72.16. Over the past week, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has declined 0.6%.

BioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions

Biomarin Pharmac (NASDAQ:BMRN) has potential upside of 54.5% based on a current price of $72.16 and analysts' consensus price target of $111.48. The stock should find initial resistance at its 50-day moving average (MA) of $81.72 and further resistance at its 200-day MA of $88.60.

SmarTrend recommended that its subscribers protect gains by selling shares of Biomarin Pharmac on July 8th, 2019 by issuing a Downtrend alert when the shares were trading at $80.73. Since that call, shares of Biomarin Pharmac have fallen 9.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows biomarin pharmac

Ticker(s): BMRN